Modification of a Tumor Antigen Determinant To Improve Peptide/MHC Stability Is Associated with Increased Immunogenicity and Cross-Priming a Larger Fraction of CD8+ T Cells.

Autor: Watson, Alan M.1,2, Mylin, Lawrence M.3, Thompson, Megan M.3,4, Schell, Todd D.1 tschell@hmc.psu.edu
Zdroj: Journal of Immunology. 12/15/2012, Vol. 189 Issue 12, p5549-5560. 12p.
Databáze: Academic Search Ultimate